Renal concentrating defect in mice lacking group IV cytosolic phospholipase A2

被引:48
|
作者
Downey, P
Sapirstein, A
O'Leary, E
Sun, TX
Brown, D
Bonventre, JV
机构
[1] Massachusetts Gen Hosp, Med Serv, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Anesthesia Serv, Charlestown, MA 02129 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA
[6] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02129 USA
关键词
mouse; osmolality; kidney concentrating mechanism; prostaglandin; aquaporin; eicosanoid;
D O I
10.1152/ajprenal.2001.280.4.F607
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Eicosanoids regulate various cellular functions that are important in physiological and pathophysiological processes. Arachidonic acid is released from membranes by phospholipase A(2) (PLA(2)) activity. Activated macrophages derived from mice lacking the 85-kDa group IV cytosolic PLA(2) (cPLA(2)) have a markedly reduced release of prostaglandin E-2 and leukotrienes B-4 and C-4. Under basal conditions and after furosemide, urinary prostaglandin E-2 excretion is reduced in cPLA(2)-knockout (cPLA(2)(-/-)) mice. Serum creatinine, Na+, K+, and Ca2+ concentrations, glomerular filtration rate, and fractional excretion of Na+ and K+ are not different in cPLA(2)(-/-) and cPLA(2)(-/-) mice. Maximal urinary concentration is lower in 48-h water-deprived cPLA(2)(-/-) mice compared with cPLA(2)(+/+) animals (1,934 +/- 324 vs. 3,541 +/- 251 mmol/kgH(2)O). Plasma osmolality is higher (337 +/- 5 vs. 319 +/- 3 mmol/kgH(2)O) in cPLA(2)(-/-) mice that lose a greater percentage of their body weight (20 +/- 2 vs. 13 +/- 1%) compared with cPLA(2)(+/+) mice after water deprivation. Vasopressin does not correct the concentrating defect. There is progressive reduction in urinary osmolality with age in cPLA(2)(-/-) mice. Membrane-associated aquaporin-1 (AQP1) expression, identified by immunocytochemical techniques, is reduced markedly in proximal tubules of older cPLA(2)(-/-) animals but is normal in thin descending limbs. However, Western blot analysis of kidney cortical samples revealed an equivalent AQP1 signal intensity in cPLA(2)(+/+) and cPLA(2)(-/-) animals. Young cPLA(2)(-/-) mice have normal proximal tubule AQP1 staining. Collecting duct AQP2, -3, and -4 were normally expressed in the cPLA(2)(-/-) mice. Thus mice lacking cPLA(2) develop an age-related defect in renal concentration that may be related to abnormal trafficking and/or folding of AQP1 in the proximal tubule, implicating cPLA(2) in these processes.
引用
收藏
页码:F607 / F618
页数:12
相关论文
共 50 条
  • [1] Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity
    Klivenyi, P
    Beal, MF
    Ferrante, RJ
    Andreassen, OA
    Wermer, M
    Chin, MR
    Bonventre, JV
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (06) : 2634 - 2637
  • [2] The ABC's of group IV cytosolic phospholipase A2
    Lucas, KK
    Dennis, EA
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2004, 1636 (2-3): : 213 - 218
  • [3] Cellular regulation of cytosolic group IV phospholipase A2 by phosphatidylinositol bisphosphate levels
    Balsinde, J
    Balboa, MA
    Li, WH
    Llopis, J
    Dennis, EA
    JOURNAL OF IMMUNOLOGY, 2000, 164 (10): : 5398 - 5402
  • [4] Presence of secretory group IIa and V phospholipase A2 and cytosolic group IVα phospholipase A2 in chondrocytes from patients with rheumatoid arthritis
    Leistad, L
    Feuerherm, AJ
    Ostensen, M
    Faxvaag, A
    Johansen, B
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (06) : 602 - 610
  • [5] Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2
    Balsinde, J
    Balboa, MA
    Dennis, EA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 7951 - 7956
  • [6] Discrete role for cytosolic phospholipase A2α in platelets:: Studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A2
    Wong, DA
    Kita, Y
    Uozumi, N
    Shimizu, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03): : 349 - 357
  • [7] Secretory Group V Phospholipase A2 Regulates The Human Endothelial Cell Barrier Function Through Activation Of Cytosolic Group Iv Phospholipase A2
    Meliton, L. N.
    Munoz, N. M.
    Meliton, A. Y.
    Dudek, S. M.
    Leff, A. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [8] Arachidonate release and prostaglandin production by group IVC phospholipase A2 (cytosolic phospholipase A2γ)
    Murakami, M
    Masuda, S
    Kudo, I
    BIOCHEMICAL JOURNAL, 2003, 372 : 695 - 702
  • [9] Renal Cytosolic Phospholipase A2 Mediates AKI in Humans
    Asowata, Evans O.
    Krause, Fynn N.
    Romoli, Simone
    Ling, Stephanie
    Tan, Jennifer Y.
    Musial, Barbara
    Huang, MargaretM.
    Mahbubani, KrishnaaT.
    Griffin, Julian L.
    Pernille, B.
    Hansen, Laerkegaard
    Saeb-Parsy, Kourosh
    Woollard, Kevin
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 135 - 136
  • [10] Group IV Cytosolic Phospholipase A2[alpha] is Critical for Norepinephrine-Induced Hypertension.
    Pingili, Ajeeth K.
    Song, Chi Yong
    Shin, Ji Soo
    Bonventre, Joseph, V
    Malik, Kafait U.
    HYPERTENSION, 2017, 70